Starovasnik Melissa's most recent trade in Twist Bioscience Corp was a trade of 4,472 Common Stock done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Twist Bioscience Corp | Melissa A. Starovasnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 4,472 | 21,627 (0%) | 0% | 0 | Common Stock | |
Twist Bioscience Corp | Starovasnik Melissa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 5,815 | 17,155 (0%) | 0% | 0 | Common Stock | |
Twist Bioscience Corp | Melissa Starovasnik | Director | Sale of securities on an exchange or to another person at price $ 26.45 per share. | 09 Feb 2023 | 1,732 | 11,340 (0%) | 0% | 26.5 | 45,820 | Common Stock |
Twist Bioscience Corp | Melissa Starovasnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 8,212 | 13,072 (0%) | 0% | 0 | Common Stock | |
Twist Bioscience Corp | Melissa Starovasnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 3,491 | 4,860 (0%) | 0% | 0 | Common Stock | |
Twist Bioscience Corp | Melissa Starovasnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 2,739 | 2,739 | - | - | Employee Stock Option (right to buy) | |
Twist Bioscience Corp | Melissa Starovasnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 1,369 | 1,369 (0%) | 0% | 0 | Common Stock |